LTA Factor of Nitrosamine | LTA Adjustment Factor Explained | Nitrosamine Risk Assessment DR. ASHIS

In this video, I explain the LTA Factor of Nitrosamines and the LTA Adjustment Factor used in nitrosamine risk assessment. This video provides a clear and practical explanation of the LTA factor, its importance in nitrosamine assessment, and how it can be considered when evaluating nitrosamine risk in pharmaceutical products. In this video: • What is the LTA Factor? • What is the LTA Adjustment Factor? • Why is the LTA factor important for Nitrosamine Risk Assessment? • How is the LTA factor applied? • Step-by-step explanation of the concept • Important considerations for pharmaceutical quality and regulatory assessment This video is intended for pharmaceutical professionals, quality assurance professionals, quality control professionals, analytical scientists, regulatory professionals, researchers, students, and anyone interested in nitrosamine risk assessment. If you find this video useful, please Like 👍, Share, and Subscribe for more videos related to Nitrosamines, Pharmaceutical Analysis, Quality Control, Regulatory Guidelines, and Pharmaceutical Quality. #Nitrosamine #LTA #NitrosamineRiskAssessment #PharmaceuticalAnalysis #Pharma 24 September 2026 FDA GUIDELINE UPDATED DR.ASHIS MATHURI CLASSES Application of Less-Than-Lifetime Adjustment to Nitrosamine Impurities Formula and Examples LTL adjusted AI = Lifetime AI X LTL factor Important Limitations Do NOT apply LTL adjustment factors to interim AI limits. Applies only to nitrosamine impurities. Not a general update for all genotoxic impurities. Intended treatment duration should be based on the labeled indication/clinical use Interim Al Limits Do NOT Apply LTL N-Nitroso-sertraline Not applicable LTL N-Nitroso-fluoxetine 7200 AI LIMIT BUT Do NOT Apply LTL N-Nitroso-ciprofloxacin 12000 AI LIMIT BUT Do NOT Apply LTL #fda #FDAGUIDELINE #CPCA #CPCAVALUES #LTL L